StoneRidge PMG Advisors, LLC’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$48K Buy
+10,125
New +$48.8K 0.03% 146

Other funds holding ABUS

StoneRidge PMG Advisors, LLC's ABUS Position: Q3 2026 in Review

StoneRidge PMG Advisors, LLC opened a new position in Arbutus Biopharma (ABUS) in Q3 2026: 10,125 shares worth $48K. The stake represents 0.03% of the portfolio and ranks #146 among its holdings.

216 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.

  • StoneRidge PMG Advisors, LLC held 10,125 shares of Arbutus Biopharma worth $48K as of Q3 2026.
  • Arbutus Biopharma was a new StoneRidge PMG Advisors, LLC position in Q3 2026.
  • Arbutus Biopharma made up 0.03% of StoneRidge PMG Advisors, LLC's portfolio in Q3 2026, its #146 holding.
  • 216 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.

Based on StoneRidge PMG Advisors, LLC's 13F filing for Q3 2026, filed 4 Nov 2026.